Aratana Therapeutics (PETX) IPO Prices at $6/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/1/2026
- Wall St set for higher open tech gains offset bond-market jitters
- Oil prices rise as China suspends fuel exports
- Amazon and these four U.S. stocks are latest additions to Goldman’s flagship list
- Elevated equity positioning, leverage could challenge stocks in Q4: JPMorgan
- Alphabet shares up in premarket trade after Gemini 4 Argon launch
- Zimbabwe helicopter crash kills six, government spokesperson says
- Apple's iOS 27 is blocking Trade Desk ads on Safari, analyst says
- DataMeds AI's Corexa Pharmacy tops $1M in monthly revenue
- S&P 500 dips, Nasdaq higher after data shows moderate inflation rise
- Mattel names Roger Lynch as chairman and CEO, replacing Ynon Kreiz
Aratana Therapeutics (PETX) IPO Opens Higher
June 27, 2013 11:28 AM EDTThe IPO for Aratana Therapeutics (NASDAQ: PETX) opened for trading at $7 after pricing 5,750,000 share IPO at $6 per share, in-line with the expected pricing.
Stifel and Lazard Capital Markets are acting as lead book-running managers for the offering. William Blair, JMP Securities and Craig-Hallum... More
